Dr. Paulina Liberman | Ocular Immunology

Why It Matters

AI‑driven diagnosis and multidisciplinary care accelerate treatment for blinding eye diseases, improving patient outcomes and setting new standards in ocular immunology.

Key Takeaways

• Dr. Liberman returned to Chile, then rejoined Wilmer Eye Institute.
• Specializes in ocular immunology, uveitis, and mucous membrane pemphigoid.
• Uses AI to differentiate true pemphigoid from mimicking conditions.
• Emphasizes personalized treatment plans and clear patient expectations.
• Highlights multidisciplinary collaboration across Wilmer specialties for better outcomes.

Summary

Dr. Paulina Liberman, an assistant professor of ophthalmology at Johns Hopkins’ Wilmer Eye Institute, discusses her journey from training at Wilmer to leading the uveitis department in Chile and returning to the institute to focus on ocular immunology. She outlines her clinical focus on inflammatory eye diseases, particularly uveitis and mucous membrane pemphigoid, and describes how her research aims to directly impact patient management.

Liberman emphasizes a multimodal treatment approach—topical drops, systemic therapy, regional injections, and surgery—tailored to each patient’s disease severity. A central component of her current work is integrating artificial‑intelligence tools to reliably distinguish true mucous membrane pemphigoid from phenotypically similar conditions, thereby guiding decisions on aggressive versus conservative therapy. Early, decisive treatment, she notes, is crucial to prevent irreversible vision loss.

She stresses the importance of setting clear expectations with patients, ensuring they understand both the therapeutic options and their role in the care process. "I try to keep my research clinically oriented," she says, highlighting a patient‑first philosophy. Liberman also points to Wilmer’s strength in collaborative care, drawing on expertise from glaucoma, cornea, pediatrics and other subspecialties to deliver comprehensive treatment.

The integration of AI diagnostics and a multidisciplinary framework positions Wilmer as a leader in managing potentially blinding ocular diseases. This model promises faster, more accurate diagnoses and personalized treatment pathways, setting a benchmark for eye‑care institutions worldwide.

Original Description

Paulina Liberman, M.D, is an assistant professor of ophthalmology specializing in ocular immunology at the Wilmer Eye Institute, Johns Hopkins Medicine, located at its East Baltimore and Odenton facilities. Dr. Liberman has focused her clinical practice on the treatment and management of uveitis, employing advanced therapeutic methods to prevent and mitigate vision loss. Her approach combines rigorous clinical care with extensive research aimed at improving treatment protocols for ocular inflammation. #uveitis #johnshopkins #wilmereye #ocularimmunologist

Meet Dr. Liberman https://profiles.hopkinsmedicine.org/provider/paulina-liberman/2703423